Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia

Nutrition

Volumn 23, Issue 3, 2007, Pages 203-210

  Piyathilake, Chandrika J ^a   Macaluso, Maurizio ^a   Brill, Ilene ^a   Heimburger, Douglas C ^a   Partridge, Edward E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cervical; Folate; Human papillomavirus; Neoplasia

Indexed keywords

FOLIC ACID; TRACE ELEMENT;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL PROTOCOL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ERYTHROCYTE MEMBRANE; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERUS CARCINOMA; VITAMIN SUPPLEMENTATION;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONFIDENCE INTERVALS; ERYTHROCYTES; FEMALE; FOLIC ACID; HUMAN PAPILLOMAVIRUS 16; HUMANS; LOGISTIC MODELS; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 33847654362     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2006.12.002     Document Type: Article

References (57)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
2. Human papillomaviruses. IARC monographs on the evaluation of carcinogenic risks to humans Volume 64 (1995), International Agency for Research on Cancer, Lyon, France
3. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B., et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85 (1993) 958-964
4. Bosch F.X., and de Sanjose S. Human papillomavirus and cervical cancer-burden and assessment of causality. National Cancer Institute monograph 31 (2003), National Cancer Institute, Bethesda 3-13
5. Sedjo R.L., Papenfuss M.R., Craft N.E., and Giuliano A.R. Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States). Cancer Causes Control 14 (2003) 319-326
6. Giuliano A.R., Papenfuss M., Nour M., Canfield L.M., Schneider A., and Hatch K. Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 6 (1997) 917-923
7. Sedjo R.L., Inserra P., Abrahamsen M., Harris R.B., Roe D.J., Baldwin S., et al. Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev 11 (2002) 353-359
8. Sedjo R.L., Fowler B.M., Schneider A., Henning S.M., Hatch K., and Giuliano A.R. Folate, vitamin B12, and homocysteine status. Findings of no relation between human papillomavirus persistence and cervical dysplasia. Nutrition 19 (2003) 497-502
9. Palan P.R., Chang C.J., Mikhail M.S., Ho G.Y., Basu J., and Romney S.L. Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions. Nutr Cancer 30 (1998) 46-52
10. Piyathilake C.J., Henao O.L., Macaluso M., Cornwell P.E., Meleth M., Heimburger D.C., et al. Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64 (2004) 8788-8793
11. ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 188 (2003) 1383-1392
12. ASCUS-LSIL Traige Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 188 (2003) 1393-1400
13. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B., et al. Epidemiologic evidence showing that human papillomavirus infection cause most cervical intraepithelial neoplasia. J Natl Cancer Inst 85 (1993) 958-964
14. Ley C., Bauer H.M., Reingold A., Schiffman M.H., Chambers J.C., Tashiro C.J., et al. Determinants of genital human papilloma virus infection in young women. J Natl Cancer Inst 83 (1991) 997-1002
15. Hellberg D., Borendal N., Sikstrom B., Nilsson S., and Mardh P.A. Comparison of women with cervical human papillomavirus infection and genital warts. I. Some behavioral factors and clinical findings. Genitourin Med 71 (1995) 88-91
16. Morrison E.A., Ho G.Y., Vermund S.H., Goldberg G.L., Kadish A.S., Kelley K.F., et al. Human papilloma virus infection and other risk factors for cervical neoplasia: a case control study. Int J Cancer 49 (1991) 6-13
17. Walker B., Figgs L.W., and Zahm S.H. Differences in cancer incidence, mortality, and survival between African Americans and Whites. Environ Health Perspect 103 Suppl 8 (1995) 275-281
18. Winkelstein Jr. W. Smoking and cervical cancer-current status: a review. Am J Epidemiol 131 (1990) 945-957
19. Romney S.L., Basu J., Vermund S., Palan P.R., and Duttagupta C. Plasma reduced and total ascorbic acid in human uterine cervix dysplasia and cancer. Ann N Y Acad Sci 498 (1987) 132-143
20. VanEenwyk J., Davis F.G., and Bowen P.E. Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 48 (1991) 34-38
21. Palan P.R., Mikhail M.S., Basu J., and Romney S.L. Plasma levels of antioxidant beta-carotene and alpha-tocopherol in uterine cervix dysplasias and cancer. Nutr Cancer 15 (1991) 13-20
22. Butterworth Jr. C.E. Effect of folate on cervical cancer. Synergism among risk factors. Ann N Y Acad Sci 669 (1992) 293-299
23. VanEenwyk J., Davis F.G., and Colman N. Folate, vitamin C, and cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1 (1992) 119-124
24. Butterworth Jr. C.E., Hatch K.D., Macaluso M., Cole P., Sauberlich H.E., Soong S.J., et al. Folate deficiency and cervical dysplasia. JAMA 267 (1992) 528-533
25. Butterworth Jr. C.E., Hatch K.D., Soong S.J., Cole P., Tamura T., Sauberlich H.E., et al. Oral folic acid supplementation for cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol 166 (1992) 803-809
26. Childers J.M., Chu J., Voigt L.F., Feigl P., Tamimi H.K., Franklin E.W., et al. Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group Intergroup study. Cancer Epidemiol Biomarkers Prev 4 (1995) 155-159
27. de Vet H.C., Knipschild P.G., Willebrand D., Schouten H.J., and Sturmans F. The effect of beta-carotene on the regression and progression of cervical dysplasia: a clinical experiment. J Clin Epidemiol 44 (1991) 273-283
28. Romney S.L., Ho G.Y., Palan P.R., Basu J., Kadish A.S., Klein S., et al. Effects of beta-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol Oncol 65 (1997) 483-492
29. Schiffman M., and Adrianza M.E. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 44 (2000) 726-742
30. Guido R., Schiffman M., Solomon D., Burke L., and ASCUS LSIL Triage Study (ALTS) Group. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 188 (2003) 1401-1405
31. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 38 (2000) 357-361
32. Piyathilake C.J., Macaluso M., Hine R.J., Richards E.W., and Krumdieck C.L. Local and systemic effects of cigarette smoking on folate and vitamin B12. Am J Clin Nutr 60 (1994) 559-566
33. Franco E.L., Rohan T.E., and Villa L.L. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 91 (1999) 506-511
34. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
35. Human papillomaviruses. IARC monographs on the evaluation of carcinogenic risks to humans Volume 64 (1995), International Agency for Research on Cancer, Lyon, France
36. Ho G.Y., Bierman R., Beardsley L., Chang C.J., and Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 12 338 (1998) 423-428
37. Richardson H., Kelsall G., Tellier P., Voyer H., Abrahamowicz M., Ferenczy A., et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomark Prevent 12 (2003) 485-490
38. Campion M.J., McCance D.J., Cuzick J., and Singer A. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 2 (1986) 237-240
39. Franceschi S., Clifford G., and Plummer M. Prospects for primary prevention of cervical cancer in developing countries. Salud Publica Mex 45 suppl 3 (2003) S430-S436
40. Duthie S.J., and Hawdon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 12 (1998) 1491-1497
41. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 94 (1977) 3290-3295
42. Fenech M. Micronutrients and genomic stability: a new paradigm for recommended dietary allowances (RDAs). Food Chem Toxicol 40 (2002) 1113-1117
43. Short B., Giuliano A., Piyathilake C.J., Nour M., and Hatch K. Hypomethylation: an early event in cervical carcinogenesis. Cancer Epidemiol Biomark Prevent 7 (1998) 901-906
44. Duensing S., and Munger K. Centrosomes, genomic instability, and cervical carcinogenesis. Crit Rev Eukaryot Gene Expr 13 (2003) 9-23
45. Cahill D.P., Kinzler K.W., Vogelstein B., and Lengauer C. Genetic instability and darwinian selection in tumours. Trends Cell Biol 9 (1999) M57-M60
46. Fenech M., Holland N., Chang W.P., Zeiger E., and Bonassi S. The Human MicroNucleus Project-an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res 428 (1999) 271-283
47. Chakrabarti R.N., and Dutta K. Micronuclei test in routine smears from uterine cervix. Eur J Gynaecol Oncol 9 (1988) 370-372
48. Cerqueira E.M., Santoro C.L., Donozo N.F., Freitas B.A., Pereira C.A., Bevilacqua R.G., and Machado-Santelli G.M. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?. Acta Cytol 42 (1998) 639-649
49. Leal-Garza C.H., Cerda-Flores R.M., Leal-Elizondo E., and Cortes-Gutierrez E.I. Micronuclei in cervical smears and peripheral blood lymphocytes from women with and without cervical uterine cancer. Mutat Res 515 (2002) 57-62
50. Macnab J.C., Adams R.L., Rinaldi A., Orr A., and Clark L. Hypomethylation of host cell DNA synthesized after infection or transformation of cell by herpes simplex virus. Mol Cell Biol 8 (1988) 1443-1448
51. Wilke C.M., Hall B.K., Hoge A., Paradee W., Smith D.I., and Glover T.W. FRA3B extends over a broad region and contains a spontaneous HPV 16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5 (1996) 187-195
52. Schiffman M., Herrero R., DeSalle R., Hildesheim A., Wacholder S., Rodriguez A.C., et al. The carcinogenicity of human papillomavirus type reflects viral evolution. Virology 337 (2005) 76-84
53. Goldie S.J., Kohli M., Grima D., Weinstein M.C., Wright T.C., Bosch F.X., Franco E., et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 96 (2004) 604-615
54. Hughes J.P., Garnett G.P., and Koutsky L. The theoretical population-level impact of a prophylactic human papillomavirus vaccine. Epidemiology 13 (2002) 631-639
55. Kulasingham S.L., and Myers E.R. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 290 (2003) 781-789
56. Selhub J., Jacques P.F., Bostom A.G., Wilson P.W., and Rosenberg I.H. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. Public Health Rev 28 (2000) 117-145
57. Lawrence J.M., Petitti D.B., Watkins M., and Umekubo M.A. Trends in serum folate after food fortification. Lancet 354 (1999) 915-916